StemBook

Login or Register
  • Home
  • About
  • Contents
  • Contributor Info
  • Resources
  • eAlerts

Welcome to HSCI StemCenter

The Harvard Stem Cell Institute (HSCI) unites scientists at Harvard and its affiliated hospitals with the shared goal of advancing stem cell research to treat injury and disease and the analysis of related political, legal, and ethical issues. The HSCI StemCenter publishes StemBook which provides current, peer-reviewed chapters on topics related to stem cell biology; as well as timely perspectives, interviews, and news. It serves as a resource for the stem cell research community, educators, and the interested non-specialist as well as a tool to foster discussion and build community among its readers. The Stem Center also provides links to useful biological resources such as genes, antibodies and protocols; links to key events and ability to discuss about them.

Become a member now

StemBook Home

StemBook is a comprehensive, open-access collection of original, peer-reviewed chapters covering topics related to Stem Cell Biology. Read More

Cellular and nuclear reprogramming
Genomics and proteomics
Renewal
Ectoderm specification and differentiation
Germ cell and somatic stem cell biology in reproduction
Stem cell immunology
Endoderm specification and differentiation
Mesoderm specification and differentiation
Therapeutic prospects
Epigenetics
Niche biology, homing, and migration
Tissue engineering

New Chapters

The chromatin signature of pluripotent cells
Limbal epithelial stem cells of the cornea

News

Stem Cell Research Funding Update

News, NPR: Science Friday 20 May 2009

In March, President Obama signed an executive order directing the government to change its policies regarding the funding of embryonic stem cell research. Under rules put in place by President Bush, federal funding for embryonic stem cell work was limited to research involving 23 stem cell lines that had already been created. A public comment period on rules implementing President Obama's revision to that policy is scheduled to close next week - but, according to attorney Patrick Taylor of Harvard Medical School, the proposed rules may not have the effect most people think. Due to new informed consent regulations in the rules that apply retroactively, Taylor argues, even work done using the currently approved 'Presidential Lines' could lose federal funding once the new rules go into effect. To listen to this broadcast, click here

  • Login or register to post comments
  • Read more

Powered by the Scientific Collaborative Framework (SCF).

The Science Collaboration Framework is a project of the Initiative in Innovative Computing at Harvard University in collaboration with the Harvard Stem Cell Institute, based on the Drupal open source content management system.
Copyright 2008-2009 by The President and Fellows of Harvard College. Drupal is copyright by the individual Drupal contributors.
SCF and Drupal are both licensed under the GPL version 2 software license.
Creative Commons License
All content unless otherwise noted is licensed under a Creative Commons Attribution 3.0 Unported License.